{
    "clinical_study": {
        "@rank": "114223", 
        "arm_group": [
            {
                "arm_group_label": "0,9% NaCl flush", 
                "arm_group_type": "Active Comparator", 
                "description": "for children enrolled in this group, the nurse will perform the flushing of peripheral venous catheter using flush-solution as a bolus with saline 0.9% NaCl in the amount (ml) needed to fill the entire circuit of the catheter. The flushing will be performed routinely at the end of each fleboclisis"
            }, 
            {
                "arm_group_label": "Heparin 50U/ml", 
                "arm_group_type": "Experimental", 
                "description": "for children enrolled in this group, the nurse will perform the washing of peripheral venous catheter using flush-solution as a bolus with heparin 50U/ml in the amount (ml) needed to fill the entire circuit of the catheter. The washing will be performed routinely at the end of each fleboclis"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to verify if the periodic flush with normal saline 0.9% NaCl causes\n      a longer or equal duration of patency of peripheral venous catheters, compared with heparin\n      solution 50 U / ml flush, in children from 2 years to 14 years. Only 22 and 24 gauge\n      catheters Will be included in the study.The study will assess in particular:\n\n        -  the difference of permanence in situ of the device\n\n        -  the difference in incidence of complications (in detail: obstruction, phlebitis,\n           thrombocytopenia, systemic anticoagulation)\n\n        -  the difference in costs between use of saline normal saline 0.9% NaCl solution and\n           heparinized 50 U / ml."
        }, 
        "brief_title": "Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Infection of Intravenous Catheter", 
            "Phlebitis", 
            "Extravasation of Diagnostic and Therapeutic Materials"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Extravasation of Diagnostic and Therapeutic Materials", 
                "Phlebitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age between 2 years and 14 years old\n\n          -  Medical prescription of intravenous antibiotic therapy for at least 2 doses on the\n             day\n\n          -  Presence of informed consent to participate to the study provided by the parents\n\n          -  No known hypersensitivity to heparin\n\n          -  No known hypersensitivity to the patch fixing materials (polyurethane and / or glue)\n\n          -  Absence of diseases buoyancy coagulation (haemophilias and / or thrombophilias)\n\n          -  No antecedents trombopenie dued to the use of any type of heparin or a pentosan\n             polysulfate\n\n          -  No existing treatment based on corticosteroids and / or anti-inflammatory\n\n        Exclusion Criteria:\n\n          -  age outside the range 2 - 14 years\n\n          -  children for which there is no prescription of intravenous antibiotic therapy for at\n             least 2 times a day\n\n          -  children for which the parents have not consented to the study\n\n          -  children with known hypersensitivity to heparin\n\n          -  children with known hypersensitivity to the patch fixing materials (polyurethane and\n             / or adhesive)\n\n          -  children with disease-causing buoyancy coagulation (Hemophilia and / or\n             thrombophilia)\n\n          -  children with antecedents of trombopenie occurring by the use of any type of heparin\n             or of a pentosan polyphosphate\n\n          -  children in treatment with corticosteroids and / or anti-inflammatory"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "14 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "52", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01794767", 
            "org_study_id": "Heparin2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "0,9% NaCl flush", 
                "description": "Normal Saline solution", 
                "intervention_name": "0,9% NaCl flush", 
                "intervention_type": "Drug", 
                "other_name": "Normal Saline"
            }, 
            {
                "arm_group_label": "Heparin 50U/ml", 
                "description": "Heparin solution", 
                "intervention_name": "Heparin 50U/ml", 
                "intervention_type": "Drug", 
                "other_name": "Heparin solution 50 U/ml, Epsodilave"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Calcium heparin", 
                "Heparin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "peripheral venous catheter, children.", 
        "lastchanged_date": "February 15, 2013", 
        "location": {
            "contact": {
                "email": "d.ciofi@meyer.it", 
                "last_name": "Daniele Ciofi, RN, MSN", 
                "phone": "+390555662417"
            }, 
            "facility": {
                "address": {
                    "city": "Florence", 
                    "country": "Italy", 
                    "state": "Tuscany", 
                    "zip": "50139"
                }, 
                "name": "Meyer Children Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children", 
        "overall_contact": {
            "email": "filippo.festini@unifi.it", 
            "last_name": "Filippo Festini, RN, BSN, MSN", 
            "phone": "+393472108993"
        }, 
        "overall_official": {
            "affiliation": "University of Florence", 
            "last_name": "Filippo Festini, RN, BSN, MSN", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Average length of stay on site of the catheter measured in hours", 
            "safety_issue": "No", 
            "time_frame": "participants will be followed for the duration on site of the first peripheral venous catheter inserted to each recruited subject, i.e. for an expected average of 10 dayse"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01794767"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Florence", 
            "investigator_full_name": "Filippo Festini", 
            "investigator_title": "Professor of Nursing", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence of complications extimated overall and by type of complication", 
                "safety_issue": "No", 
                "time_frame": "participants will be followed for the duration on site of the first peripheral venous catheter inserted to each recruited subject, i.e. for an expected average of 10 days"
            }, 
            {
                "measure": "Average cost for the maintenance of the catheter of each subject (pro day and in total)", 
                "safety_issue": "No", 
                "time_frame": "participants will be followed for the duration on site of the first peripheral venous catheter inserted to each recruited subject, i.e. for an expected average of 10 days"
            }
        ], 
        "source": "University of Florence", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Florence", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}